Author: Federico Bernal
Fed is the acting chief of the Research Advancement Programs branch in DRCB, and lead for the COBRE Phase 1 and Phase 2 programs and manages COBRE, IDeA-CTR, and SuRE grants in the Division for Research Capacity Building. His scientific background is in synthetic organic chemistry and chemical biology.
Posts by Federico Bernal
UPDATE: These positions are now closed.
We’re recruiting accomplished scientists for positions in our Division of Extramural Activities (DEA); Division for Research Capacity Building (DRCB); Division of Genetics and Molecular, Cellular, and Developmental Biology (GMCDB); and Division of Pharmacology, Physiology, and Biological Chemistry (PPBC). The successful applicants will be responsible for scientific and administrative review or management of a portfolio of research and/or research training grants and career development awards.
Continue reading “Wanted: NIGMS Scientific Review and Program Officers”
UPDATE: The SuRE webinar occurred on April 2. The video and presentation slides [PDF] are now available.
We’re pleased to announce that two funding opportunities for the Support for Research Excellence (SuRE) program have been reissued.
SuRE awards support investigator-initiated research projects in NIH mission areas and are open to faculty at institutions that award bachelor and/or graduate science degrees, receive limited NIH research support, and either serve a substantial number of students supported by Pell grants or are historically Black colleges and universities or Tribal colleges and universities. Faculty investigators who aren’t currently program directors/principal investigators (PD/PIs) of an active NIH research project grant are eligible to apply for a SuRE award (PAR-24-144). Faculty who haven’t had any prior independent research funding as PD/PIs are encouraged to apply for the SuRE-First award (PAR-24-145).
Continue reading “SuRE R16 Program Funding Announcements and Upcoming Webinar”
UPDATE: The video and slides [PDF] for this webinar are now available.
We’re pleased to announce that the Centers of Biomedical Research Excellence (COBRE) Phase 3 notice of funding opportunity (NOFO) (PAR-23-216) has been reissued. The COBRE program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions. The goal of this NOFO is to solidify the research base built in Phases 1 and 2 through continued support of research and research infrastructure and to implement strategies to sustain research excellence beyond COBRE funding.
Application due date: September 26, 2023
Earliest start date: July 2024
Continue reading “Centers of Biomedical Research Excellence Phase 3 Funding Opportunity and Upcoming Webinar”
UPDATE: The webinar slides [PDF] and video are now available.
I’m pleased to announce that the Centers of Biomedical Research Excellence (COBRE) Phase 2 funding opportunity announcement (FOA) (PAR-23-063) has been reissued. The COBRE program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions. The goal of this FOA is to strengthen successful Phase 1 centers through further research infrastructure improvements and continued development of investigators with shared scientific interests who can compete effectively for independent research funding.
Application receipt date: May 29, 2023
Earliest start date: April 2024
Continue reading “Centers of Biomedical Research Excellence (COBRE) Phase 2 Funding Opportunity and Upcoming Webinar”
UPDATE: The webinar slides [PDF] and video are now available.
We’re pleased to announce that we’ve published two notices of special interest (NOSIs) requesting applications to PAR-22-250, Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional), to build research capacity in data sciences (NOT-GM-23-011) and women’s health (NOT-GM-23-012) in IDeA states.
These NOSIs highlight the Office of Data Science Strategy’s interest in supporting meritorious applications on data science relevant to biomedical research, and the Office of Research on Women’s Health’s interest in supporting a meritorious application on women’s health.
Continue reading “COBRE Phase 1 Funding Opportunities for Data Sciences and Women’s Health Research and Upcoming Webinar”
UPDATE: The slides [PDF] and video for this webinar are now available.
I’m pleased to announce that the Centers of Biomedical Research Excellence (COBRE) Phase 2 funding opportunity announcement (FOA) (PAR-22-163) has been reissued. The COBRE program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions. The goal of this FOA is to strengthen successful Phase 1 centers through further research infrastructure improvements and continued development of investigators with shared scientific interests who can compete effectively for independent research funding.
Continue reading “Centers of Biomedical Research Excellence (COBRE) Phase 2 Funding Opportunity and Upcoming Webinar”
UPDATE: The video and slides [PDF] from this webinar are now available.
If you’re planning to apply for a Phase 1, 2, or 3 Centers of Biomedical Research Excellence (COBRE) grant, it’s important that you attend our upcoming webinar:
Wednesday, October 27, 3:00-4:30 p.m. ET
During the webinar, we’ll present an overview of the COBRE program’s objectives, eligibility and reporting requirements, and other key aspects of the funding opportunity announcements. We’ll also answer any questions that you have.
Continue reading “Webinar for COBRE Program Applicants and Grantees”
We’re pleased to announce the availability of administrative supplements to the Institutional Development Awards (IDeA). We invite eligible investigators to submit proposals in response to the following notices:
Continue reading “Administrative Supplements for Institutional Development Awards”
